Accueil>>Signaling Pathways>> Metabolism>> Dyslipidemias>>1,2,3-Trihexanoyl-rac-glycerol

1,2,3-Trihexanoyl-rac-glycerol (Synonyms: Glycerol trihexanoate, NSC 406885, Tricaproin, Trihexanoin)

Catalog No.GC45285

 

Products are for research use only. Not for human use. We do not sell to patients.

1,2,3-Trihexanoyl-rac-glycerol Chemical Structure

Cas No.: 621-70-5

Taille Prix Stock Qté
250mg
49,00 $US
En stock
500mg
94,00 $US
En stock
1g
178,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1,2,3-Trihexanoyl-rac-glycerol is a triacylglycerol that contains hexanoic acid at the sn-1, sn-2, and sn-3 positions. Dietary administration of 1,2,3-trihexanoyl-rac-glycerol reduces serum cholesterol levels in rats compared to corn oil-fed control animals.1 It also decreases plasma cholesterol levels and glutamyl transpeptidase activity, increases plasma LDL, HDL, and protein levels, and reduces diarrhea rate in weaned piglets when administered as 0.5% of the diet.2

References
1. Clifford, A.J., Smith, L.M., Creveling, R.K., et al. Effects of dietary triglycerides on serum and liver lipids and sterol excretion of rats. J. Nutr. 116(6), 944-956 (1986).
2. Wu, T., Li, K., Yi, D., et al. Dietary supplementation with trihexanoin enhances intestinal function of weaned piglets. Int. J. Mol. Sci. 19(10), E3277 (2018).

Avis

Review for 1,2,3-Trihexanoyl-rac-glycerol

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1,2,3-Trihexanoyl-rac-glycerol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.